3.4.5 Vical technology

Vical is using patented technology to develop gene therapies that involve only the desired DNA (“Naked DNA”), thereby avoiding the complications of using a virus. These vaccines could potentially be used to reduce the chances of contracting the disease, as well as boost the immune response of the body once infection has occurred. Similar vaccines are now in early clinical trials for treatment of AIDS. Vical technology is licensed by Merck & Co.